Severe Cutaneous Adverse Reactions to Augmentin

Clinical Presentation and Assessment

Mucosal involvement is a danger sign for severe cutaneous adverse reactions, including Stevens-Johnson Syndrome/toxic epidermal necrolysis, which present with hemorrhagic erosions of mucous membranes, painful or burning mucosa, and fever, as reported by the Clinical Microbiology and Infection journal 1
Systemic symptoms such as fever ≥38.5°C, malaise, or organ involvement suggest severe reactions requiring hospitalization, according to the Clinical Microbiology and Infection journal 1
Extent of mucosal involvement, including hemorrhagic erosions, painful burning sensation, or involvement of multiple mucosal surfaces, indicate severe reactions, as stated in the Clinical Microbiology and Infection journal 1
Skin findings, including accompanying skin lesions such as vesicles, crusts, grey-violaceous discoloration, pustules, purpura, or skin detachment, should be evaluated, as recommended by the Clinical Microbiology and Infection journal 1
Reactions occurring within the first week are more concerning for immediate hypersensitivity, while delayed reactions (days to weeks) may represent T-cell mediated reactions, according to the Journal of Allergy and Clinical Immunology 2

If severe features are present, hospitalization for monitoring and supportive care is recommended, as stated in the Clinical Microbiology and Infection journal 1
Consider dermatology and allergy consultation for patients with severe cutaneous adverse reactions, as suggested by the Clinical Microbiology and Infection journal 1
Documenting the reaction as a severe drug reaction in the medical record is crucial, as emphasized by the Clinical Microbiology and Infection journal 1
For non-severe features, observation for progression over 24-48 hours and consideration of alternative antibiotics if infection treatment must continue are recommended, according to the Clinical Microbiology and Infection journal 1 and Praxis Medical Insights 3

For respiratory infections, cefdinir, cefuroxime, or cefpodoxime are first-line alternatives, with cefdinir preferred for better patient acceptance, as stated in Praxis Medical Insights 3
Second and third-generation cephalosporins have negligible cross-reactivity with penicillins for non-Type I reactions, according to Praxis Medical Insights 3
Avoiding all beta-lactams is recommended if the oral lesions are accompanied by urticaria, angioedema, or respiratory symptoms suggesting anaphylaxis, as advised by the Clinical Microbiology and Infection journal 1
Consider allergy referral if the patient requires beta-lactam antibiotics in the future, as formal testing can clarify whether this was true hypersensitivity versus other causes, according to Clinical Reviews in Allergy and Immunology 4 and the Journal of Allergy and Clinical Immunology 2